A clinical trial: Aqualizer ™ therapy and its effects on myopathies or temporomandibular dysfunctions. Part I: Objective parameters.

Objective: Symptoms of temporomandibular dysfunction (TMD) may include pain in the muscles or restrictions opening the mouth. The aim of this study was to assess the effects of initial Aqualizer™ therapy.

Methods: Group 1 received initial Aqualizer™ therapy before definitive hard splint; Group 2 received no initial therapy.

A clinical trial: Aqualizer ™ therapy and its effects on myopathies or temporomandibular dysfunctions. Part II: Subjective parameters.

Objective: Temporomandibular dysfunction (TMD) reduces patients' quality of life (QoL). The aim was to assess the effects of initial Aqualizer™ therapy.

Methods: Group 1 (initial Aqualizer™ therapy) before definitive splint therapy or Group 2 (no initial therapy).